[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338328-105":59,"doc-detail-338328-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identification-of-kifc1-as-a-putative-vulnerability-in-lung-cancers-with-centrosome-amplification-article","Identification of KIFC1 as a putative vulnerability in lung cancers with centrosome amplification - Article","","Centrosome amplification (CA) is a frequent feature across lung and other malignancies, driving genomic instability while also generating mitotic stress that threatens cellular integrity. To exploit CA-linked adaptive mechanisms as therapeutic vulnerabilities, the study combined a CRISPR/Cas9 functional genomics screen with tumor genomic analyses. KIFC1 (HSET) emerged as a CA-specific vulnerability in lung adenocarcinoma (LUAD), with KIFC1 levels correlating positively with CA and poorer outcomes. KIFC1 loss-of-function sensitized LUAD to CA, impairing extra-centrosome clustering and promoting lethal multipolar divisions, supporting KIFC1 inhibition as a strategy to push genomic instability to fatal levels.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-of-kifc1-as-a-putative-vulnerability-in-lung-cancers-with-centrosome-amplification-article/338328/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-of-kifc1-as-a-putative-vulnerability-in-lung-cancers-with-centrosome-amplification-article/338328.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main biological problem addressed by the study?","Question",{"text":112,"@type":113},"The study focuses on how lung cancer cells cope with centrosome amplification (CA), a condition that can cause mitotic errors and cell death if not managed.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers identify KIFC1 as a vulnerability?",{"text":117,"@type":113},"They integrated a CRISPR/Cas9 functional genomics screen with tumor genomic analyses to detect genetic dependencies linked to CA in lung cancer.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does KIFC1 play in CA-positive lung adenocarcinoma?",{"text":121,"@type":113},"KIFC1 expression correlated with CA in LUAD and was associated with worse patient outcomes. KIFC1 loss-of-function sensitized LUAD cells to CA by reducing their ability to cluster extra centrosomes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338328,1790148868,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Cancer Gene [Therapy](Therapy www.nature.com/cgt)[ www.nature.com/cgt](Therapy www.nature.com/cgt)  \nARTICLE OPEN   \nIdentiﬁcation of KIFC1 as a putative vulnerability in lung cancers with centrosome ampliﬁcation  \nChristopher Zhang 1,2,10, Benson Z. Wu1,2,10, Caterina Di Ciano-Oliveira2, Yin Fang Wu2, Sharon S. Khavkine Binstock1,2, Isabel Soria-Bretones3, Nhu-An Pham3, Andrew J. Elia3, Raj Chari4, Wan L. Lam 5,6, Mark R. Bray3, Tak W. Mak3,7,8, Ming-Sound Tsao 1,3,8, David W. Cescon 3,9 and Kelsie L. Thu 1,2 ✉  \n© The Author(s) 2024  \n\n|  | Centrosome ampliﬁcation (CA), an abnormal increase in the number of centrosomes in the cell, is a recurrent phenomenon in lung and other malignancies. Although CA promotes tumor development and progression by inducing genomic instability (GIN), it also induces mitotic stress that jeopardizes cellular integrity. CA leads to the formation of multipolar mitotic spindles that can cause lethal chromosome segregation errors. To sustain the beneﬁts of CA by mitigating its consequences, malignant cells are dependent on adaptive mechanisms that represent therapeutic vulnerabilities. We aimed to discover genetic dependencies associated with CAin lung cancer. Combining a CRISPR/Cas9 functional genomics screen with tumor genomic analyses, we identiﬁed the motor protein KIFC1, also known as HSET, as a putative vulnerability speciﬁcally in lung adenocarcinoma (LUAD) with CA. KIFC1 expression was positively correlated with CA in LUAD and associated with worse patient outcomes, smoking history, and indicators of GIN. KIFC1 loss-of-function sensitized LUAD cells with high basal KIFC1 expression to potentiation of CA, which was associated with a diminished ability to cluster extra centrosomes into pseudo-bipolar mitotic spindles. Our work suggests that KIFC1 inhibition represents a novel approach for potentiating GIN to lethal levels in LUAD with CA by forcing cells to divide with multipolar spindles, |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| rationalizing further studies to investigate its therapeutic potential. |  |  |\n|  | Cancer Gene Therapy (2024) 31:1559–1570; [https://doi.org/10.1038/s41417-024-00824-1](https://doi.org/10.1038/s41417-024-00824-1) |  |\n|  |  |  |\n\nINTRODUCTION  \nLung cancer (LC) is the leading cause of cancer death worldwide [1] and is broadly divided into small-cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) . Of the various NSCLC subtypes, lung adenocarcinoma (LUAD) is most prevalent, accounting for ~40% of all cases [2] . Although advances in targeted therapies and immunotherapy have expanded the treatment landscape for LC, the 5-year net survival rate has not risen above 22%[3] . This highlights the need for new therapeutic approaches that target mechanisms supporting lung tumor growth and progression.  \nCentrosomes are microtubule-organizing organelles with important roles in cell motility and polarity, and generation of mitotic spindles required to segregate chromosomes during mitosis [4] . Centrosome ampliﬁcation (CA), an abnormal increase in the number of centrosomes in a cell, is a common feature of many malignancies including LC [4–6] . Several routes to CA have been described including DNA damage, failure of cytokinesis, centriole overduplication, and carcinogen exposure [7–10] . The presence of extra centrosomes has been shown to promote genomic instability (GIN) [11, 12] which fuels tumor adaptation to  \nstress such as that induced by anti-cancer therapy [13] . This ﬁtness advantage may explain the prevalence of CA in cancer; however, having supernumerary centrosomes comes with a cost. Cells with CA are prone to forming multipolar mitotic spindles that if left uncorrected cause severe chromosome segregation errors, mitotic catastrophe, and cell death [14] . Thus, cancer cells must manage extra centrosomes to prevent multipolar divisions and their delet","cbCaiv5VZyjkRqvz","https://ap.wps.com/l/cbCaiv5VZyjkRqvz","pdf",1161259,12,"English","# Introduction\n## Lung cancer background and treatment challenge\n## Centrosomes, centrosome amplification, and genomic instability\n## Coping mechanisms and therapeutic vulnerabilities","[{\"question\":\"What is the main biological problem addressed by the study?\",\"answer\":\"The study focuses on how lung cancer cells cope with centrosome amplification (CA), a condition that can cause mitotic errors and cell death if not managed.\"},{\"question\":\"How did the researchers identify KIFC1 as a vulnerability?\",\"answer\":\"They integrated a CRISPR/Cas9 functional genomics screen with tumor genomic analyses to detect genetic dependencies linked to CA in lung cancer.\"},{\"question\":\"What role does KIFC1 play in CA-positive lung adenocarcinoma?\",\"answer\":\"KIFC1 expression correlated with CA in LUAD and was associated with worse patient outcomes. KIFC1 loss-of-function sensitized LUAD cells to CA by reducing their ability to cluster extra centrosomes.\"}]","Identification of KIFC1 as a putative vulnerability in lung cancers with centrosome amplification - Article | PDF",1790023081,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1e499f622e064a5281911e57b560084.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b9e726bd03b327dcc2c32b658c3a5a33.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/912f4875dbd7a381c06953e5b31c15c3.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6a0d8017d94a6867c4aa386b1b0346d6.webp",980,1301]